Go Pro
→ Trump's gold order: the announcement they won't put on the front page (From Reagan Gold Group) (Ad)tc pixel Free DCGO Stock Alerts

DocGo (DCGO) Financials

DocGo logo
$0.64 +0.01 (+1.18%)
Closing price 04:00 PM Eastern
Extended Trading
$0.62 -0.03 (-4.00%)
As of 07:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for DocGo

Annual Income Statements for DocGo

This table shows DocGo's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -14 24 35 6.86 20 -182
Consolidated Net Income / (Loss)		 -15 19 31 10 13 -196
Net Income / (Loss) Continuing Operations		 -15 19 31 10 13 -196
Total Pre-Tax Income 		-15 20 23 16 28 -187
Total Operating Income		 -15 15 22 15 29 -178
Total Gross Profit		 31 110 155 195 214 99
Total Revenue		 94 319 441 624 617 322
Operating Revenue		 94 319 441 624 617 322
Total Cost of Revenue		 63 209 286 429 403 223
Operating Cost of Revenue		 63 209 286 429 403 223
Total Operating Expenses		 46 94 133 180 185 277
Selling, General & Admin Expense		 35 75 103 137 139 133
Marketing Expense		 0.75 4.76 4.76 2.80 1.51 1.42
Research & Development Expense		 1.19 3.32 5.38 11 12 14
Depreciation Expense		 5.51 7.51 11 16 16 16
Impairment Charge		 - 0.00 - 0.00 0.00 89
Other Special Charges / (Income)		 3.75 3.91 8.78 13 17 24
Total Other Income / (Expense), net		 0.13 4.44 0.95 1.24 -0.94 -9.47
Interest & Investment Income		 0.00 -0.07 0.77 1.34 -2.25 -1.79
Other Income / (Expense), net		 0.33 5.13 0.18 -0.10 1.31 -7.67
Income Tax Expense		 0.17 0.62 -7.96 6.24 14 8.87
Net Income / (Loss) Attributable to Noncontrolling Interest		 -0.44 -4.56 -3.84 3.19 -6.63 -14
Basic Earnings per Share		 ($0.25) $0.30 $0.34 $0.07 $0.20 ($1.84)
Weighted Average Basic Shares Outstanding		 58.37M 80.29M 101.23M 103.51M 102.40M 99.07M
Diluted Earnings per Share		 ($0.25) $0.25 $0.34 $0.06 $0.18 ($1.84)
Weighted Average Diluted Shares Outstanding		 58.37M 94.86M 102.98M 105.62M 109.42M 99.07M
Weighted Average Basic & Diluted Shares Outstanding		 - 100.17M 102.51M 104.17M 101.98M 98.75M

Quarterly Income Statements for DocGo

This table shows DocGo's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 4.76 7.57 11 6.53 5.50 -3.26 -9.41 -11 -28 -134 -15
Consolidated Net Income / (Loss)		 4.63 7.99 11 5.86 4.55 -7.65 -11 -13 -30 -142 -17
Net Income / (Loss) Continuing Operations		 4.63 7.99 11 5.86 4.55 -7.65 -11 -13 -30 -142 -17
Total Pre-Tax Income 		9.16 12 16 9.57 9.03 -6.58 -15 -18 -43 -112 -17
Total Operating Income		 8.71 12 16 10 10 -7.47 -14 -17 -42 -105 -19
Total Gross Profit		 55 -98 192 165 139 -157 96 80 71 -149 76
Total Revenue		 187 199 192 165 139 121 96 80 71 75 76
Operating Revenue		 187 199 192 165 139 121 96 80 71 75 76
Total Cost of Revenue		 132 297 0.00 0.00 0.00 278 0.00 0.00 0.00 223 0.00
Total Operating Expenses		 46 -110 176 155 129 -150 110 98 113 -44 94
Selling, General & Admin Expense		 34 44 40 35 29 35 33 31 30 39 31
Marketing Expense		 1.61 0.20 0.34 0.39 0.38 0.40 0.33 0.37 0.38 0.34 0.37
Research & Development Expense		 3.24 3.19 2.39 2.37 3.15 3.69 3.64 2.96 3.19 3.77 3.71
Depreciation Expense		 4.34 4.62 4.18 4.20 4.18 3.32 3.76 3.98 3.97 3.95 2.65
Other Operating Expenses / (Income)		 - - 125 109 89 - 65 55 53 - 52
Other Special Charges / (Income)		 3.55 3.49 4.31 4.01 3.30 5.53 4.21 4.35 5.73 9.53 5.03
Total Other Income / (Expense), net		 0.45 0.52 -0.15 -0.58 -1.10 0.90 -0.81 -0.44 -1.19 -7.03 2.03
Interest & Investment Income		 0.25 0.77 -0.45 -0.58 -0.59 -1.00 -0.47 -0.48 -0.25 -0.60 -0.10
Other Income / (Expense), net		 0.20 0.56 0.30 -0.00 -0.52 1.53 -0.34 0.05 -0.95 -6.43 2.13
Income Tax Expense		 4.53 4.20 5.12 3.71 4.49 1.07 -3.72 -4.63 -14 31 0.02
Net Income / (Loss) Attributable to Noncontrolling Interest		 -0.13 0.42 -0.62 -0.67 -0.95 -4.38 -1.67 -2.13 -1.89 -8.27 -1.94
Basic Earnings per Share		 $0.05 $0.07 $0.11 $0.06 $0.05 ($0.02) ($0.09) ($0.11) ($0.28) ($1.36) ($0.15)
Weighted Average Basic Shares Outstanding		 103.87M 103.51M 103.82M 101.84M 102.07M 102.40M 101.59M 98.93M 97.81M 99.07M 98.75M
Diluted Earnings per Share		 $0.05 $0.06 $0.10 $0.06 $0.05 ($0.03) ($0.09) ($0.11) ($0.28) ($1.36) ($0.15)
Weighted Average Diluted Shares Outstanding		 104.99M 105.62M 108.51M 106.32M 106.29M 109.42M 101.59M 98.93M 97.81M 99.07M 98.75M
Weighted Average Basic & Diluted Shares Outstanding		 103.90M 104.17M 101.57M 102.32M 102.05M 101.98M 99.10M 97.81M 97.81M 98.75M 98.78M

Annual Cash Flow Statements for DocGo

This table details how cash moves in and out of DocGo's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 -17 145 -15 -92 35 -55
Net Cash From Operating Activities		 -11 -1.95 29 -64 70 34
Net Cash From Continuing Operating Activities		 -11 -1.95 29 -64 70 34
Net Income / (Loss) Continuing Operations		 -15 19 31 10 13 -196
Consolidated Net Income / (Loss)		 -15 19 31 10 13 -196
Depreciation Expense		 1.87 2.31 4.11 4.83 5.61 4.86
Amortization Expense		 3.63 4.76 6.45 12 10 10
Non-Cash Adjustments To Reconcile Net Income		 2.24 0.60 11 26 28 124
Changes in Operating Assets and Liabilities, net		 -3.61 -29 -23 -117 13 91
Net Cash From Investing Activities		 -6.04 -8.59 -38 -30 -11 -39
Net Cash From Continuing Investing Activities		 -6.04 -8.59 -38 -30 -11 -39
Purchase of Property, Plant & Equipment		 -4.36 -4.81 -3.20 -7.31 -3.61 -4.54
Acquisitions		 -1.95 -3.81 -35 -23 -2.31 -19
Purchase of Investments		 - - - 0.00 0.00 -29
Sale of Property, Plant & Equipment		 0.28 0.07 0.00 0.75 0.27 0.20
Sale and/or Maturity of Investments		 - - - 0.00 0.00 13
Other Investing Activities, net		 0.00 -0.05 - - -5.00 0.00
Net Cash From Financing Activities		 -0.81 155 -6.18 1.12 -24 -51
Net Cash From Continuing Financing Activities		 -0.81 155 -6.18 1.12 -24 -51
Repayment of Debt		 -0.80 -8.60 -3.94 -4.30 -40 -30
Repurchase of Common Equity		 0.00 0.00 -3.75 0.00 -14 -11
Payment of Dividends		 - -20 0.00 0.00 -3.14 -0.18
Issuance of Debt		 0.00 8.00 0.00 25 45 0.26
Other Financing Activities, net		 -1.51 -2.66 -0.55 -20 -12 -10
Cash Interest Paid		 0.61 0.32 0.76 0.85 2.14 1.71
Cash Income Taxes Paid		 0.12 0.62 1.51 10 5.88 6.48

Quarterly Cash Flow Statements for DocGo

This table details how cash moves in and out of DocGo's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 -57 4.96 -13 27 23 -1.24 -4.28 5.50 -31 -26 -5.67
Net Cash From Operating Activities		 -46 -5.92 -11 37 31 13 9.22 34 1.66 -10 -4.66
Net Cash From Continuing Operating Activities		 -46 -5.92 -11 37 31 13 9.22 34 1.66 -10 -4.66
Net Income / (Loss) Continuing Operations		 4.63 7.99 11 5.86 4.55 -7.65 -11 -13 -30 -142 -17
Consolidated Net Income / (Loss)		 4.63 7.99 11 5.86 4.55 -7.65 -11 -13 -30 -142 -17
Depreciation Expense		 1.63 0.13 1.43 1.48 1.37 1.32 1.22 1.21 1.25 1.18 1.27
Amortization Expense		 2.71 4.48 2.75 2.73 2.80 2.00 2.54 2.62 2.65 2.67 1.30
Non-Cash Adjustments To Reconcile Net Income		 2.17 10 5.38 4.10 4.36 14 6.14 6.16 23 89 5.02
Changes in Operating Assets and Liabilities, net		 -57 -29 -31 23 18 3.25 10 37 4.78 39 4.45
Net Cash From Investing Activities		 -1.50 -2.96 -1.70 -2.09 -1.51 -5.57 -5.29 -21 1.10 -13 1.66
Net Cash From Continuing Investing Activities		 -1.50 -2.96 -1.70 -2.09 -1.51 -5.57 -5.29 -21 1.10 -13 1.66
Purchase of Property, Plant & Equipment		 -0.80 -3.22 -0.95 -1.20 -0.79 -0.89 -1.03 -0.70 -0.88 -1.50 -0.43
Acquisitions		 -0.70 -0.21 -0.77 -0.94 -0.82 0.23 -4.36 -0.87 -0.69 -13 -0.67
Purchase of Investments		 - - - - - - 0.00 - -2.52 -3.87 -1.73
Sale of Property, Plant & Equipment		 -0.00 0.47 0.03 0.06 0.10 0.10 0.09 0.08 0.02 0.00 0.02
Sale and/or Maturity of Investments		 - - - - - - 0.00 - 5.16 5.68 4.46
Net Cash From Financing Activities		 -8.67 13 -0.88 -8.07 -7.35 -7.86 -8.52 -7.38 -33 -1.86 -2.46
Net Cash From Continuing Financing Activities		 -8.67 13 -0.88 -8.07 -7.35 -7.86 -8.52 -7.38 -33 -1.86 -2.46
Repayment of Debt		 -1.06 -1.47 -41 -1.07 -1.09 3.09 -0.00 -0.00 -30 -0.01 -0.01
Repurchase of Common Equity		 - - -4.88 -4.90 -1.30 -2.68 -5.75 -5.08 - - 0.00
Payment of Dividends		 - - - - -1.85 -1.04 0.00 - -0.18 - -1.02
Other Financing Activities, net		 -7.60 -11 -0.02 -1.84 -3.11 -7.22 -2.76 -2.30 -3.11 -1.85 -1.43
Effect of Exchange Rate Changes		 -0.46 0.87 -0.10 0.03 0.58 - 0.32 0.65 -0.65 - -0.21
Cash Interest Paid		 0.19 0.28 0.63 0.65 0.79 0.07 0.56 0.91 0.89 -0.65 0.05
Cash Income Taxes Paid		 - 0.03 0.56 0.81 5.17 0.71 1.91 4.19 0.55 -0.17 0.02

Annual Balance Sheets for DocGo

This table presents DocGo's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 100 310 393 490 456 217
Total Current Assets		 58 256 271 339 304 152
Cash & Equivalents		 32 176 157 59 89 51
Accounts Receivable		 25 78 103 262 211 93
Prepaid Expenses		 1.15 2.11 6.27 17 4.01 4.79
Other Current Assets		 - 0.00 - - 0.34 3.70
Plant, Property, & Equipment, net		 9.11 13 21 17 15 15
Total Noncurrent Assets		 33 41 101 135 136 50
Long-Term Investments		 0.00 0.59 0.60 - 0.00 16
Noncurrent Note & Lease Receivables		 7.00 9.31 9.04 12 15 17
Intangible Assets		 11 11 23 38 26 0.00
Noncurrent Deferred & Refundable Income Taxes		 - - 9.96 12 8.42 0.54
Other Noncurrent Operating Assets		 8.36 12 19 26 21 15
Other Noncurrent Nonoperating Assets		 - - - - 18 1.47
Total Liabilities & Shareholders' Equity		 100 310 393 490 456 217
Total Liabilities		 33 83 114 185 140 91
Total Current Liabilities		 23 58 100 170 122 67
Short-Term Debt		 0.66 0.63 0.66 25 35 3.09
Accounts Payable		 5.08 17 22 20 28 11
Accrued Expenses		 14 35 32 91 50 43
Other Current Liabilities		 3.50 4.73 42 34 8.57 10
Total Noncurrent Liabilities		 9.73 25 14 15 19 24
Long-Term Debt		 0.59 1.30 1.24 0.04 0.01 0.18
Other Noncurrent Operating Liabilities		 9.14 23 13 15 19 24
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 67 227 279 305 315 126
Total Preferred & Common Equity		 55 220 273 301 321 144
Total Common Equity		 55 220 273 301 321 144
Common Stock		 142 283 301 321 321 325
Retained Earnings		 -87 -64 -29 -21 -1.40 -184
Accumulated Other Comprehensive Income / (Loss)		 -0.05 -0.03 0.74 1.48 1.22 2.39
Noncontrolling Interest		 12 7.48 5.70 4.38 -5.74 -18

Quarterly Balance Sheets for DocGo

This table presents DocGo's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 356 408 390 420 491 488 494 431 408 354 209
Total Current Assets		 252 258 234 267 335 329 328 263 237 190 138
Cash & Equivalents		 170 120 109 53 41 66 89 79 104 73 36
Accounts Receivable		 80 132 118 207 283 258 234 179 123 107 94
Prepaid Expenses		 2.39 6.74 6.79 6.90 11 5.14 5.15 4.77 9.65 4.73 5.28
Other Current Assets		 - 0.00 - - - - - - - 5.12 3.25
Plant, Property, & Equipment, net		 18 22 22 22 16 16 15 15 14 14 14
Total Noncurrent Assets		 86 127 134 131 139 143 150 153 157 149 57
Long-Term Investments		 0.71 0.48 0.39 0.45 0.47 0.55 0.63 - 20 18 13
Noncurrent Note & Lease Receivables		 9.42 9.17 8.96 8.57 13 14 15 17 18 17 18
Intangible Assets		 21 39 38 39 37 36 35 27 27 18 0.64
Noncurrent Deferred & Refundable Income Taxes		 - - 11 8.91 12 14 17 12 17 31 0.81
Other Noncurrent Operating Assets		 21 31 27 27 29 31 35 47 21 21 14
Other Noncurrent Nonoperating Assets		 - - - - - - - - 4.39 4.25 11
Total Liabilities & Shareholders' Equity		 356 408 390 420 491 488 494 431 408 354 209
Total Liabilities		 85 124 106 128 176 170 169 129 121 93 98
Total Current Liabilities		 71 109 92 113 160 154 150 108 100 74 77
Short-Term Debt		 5.71 0.65 19 14 30 30 30 30 30 0.05 8.15
Accounts Payable		 22 19 6.69 8.95 26 31 35 21 10 8.05 14
Accrued Expenses		 39 31 35 59 70 63 60 41 45 51 45
Other Current Liabilities		 4.92 32 32 32 34 30 25 16 15 15 10
Total Noncurrent Liabilities		 14 15 15 15 15 16 19 21 20 20 21
Long-Term Debt		 1.46 1.27 1.58 2.04 0.03 0.03 0.02 0.00 0.00 0.20 0.17
Other Noncurrent Operating Liabilities		 12 13 13 13 15 16 19 21 20 19 21
Commitments & Contingencies		 0.00 26 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 271 284 284 292 315 318 325 302 288 261 111
Total Preferred & Common Equity		 264 279 280 288 311 315 325 309 297 271 132
Total Common Equity		 264 279 280 288 311 315 325 309 297 271 132
Common Stock		 302 310 312 316 320 317 321 318 317 318 329
Retained Earnings		 -37 -32 -34 -29 -10 -3.64 1.86 -11 -22 -50 -199
Accumulated Other Comprehensive Income / (Loss)		 -0.28 0.98 1.39 0.81 1.34 1.38 2.31 1.72 2.72 2.43 2.25
Noncontrolling Interest		 6.61 5.24 4.09 3.95 3.75 2.83 -0.31 -7.41 -9.55 -9.87 -21

Annual Metrics And Ratios for DocGo

This table displays calculated financial ratios and metrics derived from DocGo's official financial filings.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 14,375,000.00 100,069,438.00 - - - 97,813,372.00
DEI Adjusted Shares Outstanding		 14,375,000.00 100,069,438.00 - - - 97,813,372.00
DEI Earnings Per Adjusted Shares Outstanding		 -1.00 0.24 - - - -1.86
Growth Metrics		 - - - - - -
Revenue Growth		 0.00% 238.74% 38.21% 41.72% -1.24% -47.74%
EBITDA Growth		 0.00% 408.92% 18.23% -3.66% 46.19% -471.31%
EBIT Growth		 0.00% 241.97% 7.46% -32.07% 100.60% -719.13%
NOPAT Growth		 0.00% 244.04% 97.99% -68.48% 48.77% -1,002.22%
Net Income Growth		 0.00% 229.60% 60.29% -67.32% 32.96% -1,569.75%
EPS Growth		 0.00% 200.00% 36.00% -82.35% 200.00% -1,122.22%
Operating Cash Flow Growth		 0.00% 81.72% 1,582.47% -322.45% 209.52% -50.86%
Free Cash Flow Firm Growth		 0.00% 0.00% -1,750.53% -242.02% 120.76% 36.86%
Invested Capital Growth		 0.00% 47.70% 132.49% 120.48% -5.54% -74.96%
Revenue Q/Q Growth		 0.00% 0.00% -2.70% 16.95% -11.28% -12.47%
EBITDA Q/Q Growth		 0.00% 0.00% -39.53% 71.22% -29.79% -158.82%
EBIT Q/Q Growth		 0.00% 0.00% -51.15% 367.04% -37.73% -130.29%
NOPAT Q/Q Growth		 0.00% 0.00% -18.71% -38.21% -53.68% -119.99%
Net Income Q/Q Growth		 0.00% 0.00% -29.92% 9.18% -53.93% -218.40%
EPS Q/Q Growth		 0.00% 0.00% -98.18% -45.45% -33.33% -260.78%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.22% 4.20% 36.49% -40.46%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% -5.77% 52.60% 35.11%
Invested Capital Q/Q Growth		 0.00% 0.00% 14.13% 6.71% -3.36% -63.30%
Profitability Metrics		 - - - - - -
Gross Margin		 33.32% 34.43% 35.12% 31.30% 34.64% 30.65%
EBITDA Margin		 -9.48% 8.65% 7.39% 5.03% 7.44% -52.87%
Operating Margin		 -15.68% 4.82% 4.96% 2.41% 4.65% -55.26%
EBIT Margin		 -15.33% 6.43% 5.00% 2.40% 4.86% -57.64%
Profit (Net Income) Margin		 -15.73% 6.02% 6.98% 1.61% 2.17% -60.95%
Tax Burden Percent		 101.14% 96.89% 134.95% 61.67% 48.15% 104.73%
Interest Burden Percent		 101.42% 96.65% 103.51% 108.97% 92.51% 100.97%
Effective Tax Rate		 0.00% 3.11% -34.95% 38.33% 51.85% 0.00%
Return on Invested Capital (ROIC)		 -28.87% 33.57% 33.52% 4.71% 5.24% -82.08%
ROIC Less NNEP Spread (ROIC-NNEP)		 -14.52% 29.38% 32.75% 3.91% 6.21% 22.35%
Return on Net Nonoperating Assets (RNNOA)		 6.76% -20.52% -21.37% -1.27% -0.94% -6.96%
Return on Equity (ROE)		 -22.11% 13.05% 12.15% 3.44% 4.31% -89.05%
Cash Return on Invested Capital (CROIC)		 0.00% -4.95% -46.17% -70.47% 10.94% 37.80%
Operating Return on Assets (OROA)		 -14.40% 10.00% 6.26% 3.38% 6.34% -55.21%
Return on Assets (ROA)		 -14.77% 9.36% 8.75% 2.27% 2.82% -58.38%
Return on Common Equity (ROCE)		 -18.16% 12.19% 11.84% 3.38% 4.32% -93.87%
Return on Equity Simple (ROE_SIMPLE)		 -26.91% 8.73% 11.25% 3.34% 4.16% 0.00%
Net Operating Profit after Tax (NOPAT)		 -10 15 29 9.28 14 -125
NOPAT Margin		 -10.98% 4.67% 6.69% 1.49% 2.24% -38.68%
Net Nonoperating Expense Percent (NNEP)		 -14.34% 4.19% 0.78% 0.80% -0.97% -104.43%
Return On Investment Capital (ROIC_SIMPLE)		 - - 10.49% 2.81% 4.00% -96.50%
Cost of Revenue to Revenue		 66.68% 65.57% 64.88% 68.70% 65.36% 69.35%
SG&A Expenses to Revenue		 37.11% 23.50% 23.47% 21.97% 22.51% 41.42%
R&D to Revenue		 1.26% 1.04% 1.22% 1.74% 1.88% 4.21%
Operating Expenses to Revenue		 48.97% 29.62% 30.17% 28.89% 29.99% 85.91%
Earnings before Interest and Taxes (EBIT)		 -14 20 22 15 30 -186
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -8.92 28 33 31 46 -170
Valuation Ratios		 - - - - - -
Price to Book Value (P/BV)		 0.00 4.26 2.66 1.93 1.35 0.60
Price to Tangible Book Value (P/TBV)		 0.00 4.67 3.44 2.69 1.75 0.60
Price to Revenue (P/Rev)		 0.00 2.94 1.65 0.93 0.70 0.27
Price to Earnings (P/E)		 0.00 39.41 21.02 84.68 21.64 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 2.54% 4.76% 1.18% 4.62% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 14.55 4.69 2.03 1.44 0.07
Enterprise Value to Revenue (EV/Rev)		 0.00 2.41 1.31 0.88 0.60 0.01
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 27.91 17.70 17.55 8.02 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 37.54 26.20 36.85 12.26 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 51.68 19.57 59.34 26.62 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 19.97 0.00 5.23 0.12
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 12.76 0.07
Leverage & Solvency		 - - - - - -
Debt to Equity		 0.02 0.01 0.01 0.08 0.10 0.03
Long-Term Debt to Equity		 0.01 0.01 0.00 0.00 0.00 0.00
Financial Leverage		 -0.47 -0.70 -0.65 -0.33 -0.15 -0.31
Leverage Ratio		 1.50 1.39 1.39 1.51 1.53 1.53
Compound Leverage Factor		 1.52 1.35 1.44 1.65 1.41 1.54
Debt to Total Capital		 1.85% 0.84% 0.68% 7.59% 8.70% 2.54%
Short-Term Debt to Total Capital		 0.97% 0.27% 0.24% 7.58% 8.69% 2.39%
Long-Term Debt to Total Capital		 0.87% 0.57% 0.44% 0.01% 0.00% 0.14%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 17.52% 3.26% 2.03% 1.33% -1.66% -14.05%
Common Equity to Total Capital		 80.64% 95.89% 97.29% 91.08% 92.97% 111.51%
Debt to EBITDA		 -0.14 0.07 0.06 0.80 0.65 -0.02
Net Debt to EBITDA		 3.49 -6.32 -4.79 -1.09 -1.29 0.37
Long-Term Debt to EBITDA		 -0.07 0.05 0.04 0.00 0.00 0.00
Debt to NOPAT		 -0.12 0.13 0.06 2.70 2.17 -0.03
Net Debt to NOPAT		 3.02 -11.71 -5.30 -3.69 -4.29 0.51
Long-Term Debt to NOPAT		 -0.06 0.09 0.04 0.00 0.00 0.00
Altman Z-Score		 0.00 8.53 5.54 3.61 3.90 -1.49
Noncontrolling Interest Sharing Ratio		 17.85% 6.61% 2.60% 1.72% -0.22% -5.41%
Liquidity Ratios		 - - - - - -
Current Ratio		 2.49 4.42 2.71 1.99 2.50 2.26
Quick Ratio		 2.44 4.39 2.60 1.89 2.46 2.13
Cash Flow Metrics		 - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -2.19 -41 -139 29 57
Operating Cash Flow to CapEx		 -260.81% -41.14% 903.53% -939.26% 1,975.92% 793.46%
Free Cash Flow to Firm to Interest Expense		 0.00 -3.53 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 -52.07 -3.14 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 -72.03 -10.77 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - -
Asset Turnover		 0.94 1.56 1.25 1.41 1.30 0.96
Accounts Receivable Turnover		 3.79 6.17 4.86 3.42 2.61 2.12
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 10.33 29.19 25.92 32.78 38.88 21.89
Accounts Payable Turnover		 12.35 18.59 14.66 20.72 16.73 11.32
Days Sales Outstanding (DSO)		 96.42 59.12 75.14 106.72 140.00 172.08
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 29.55 19.64 24.90 17.62 21.82 32.24
Cash Conversion Cycle (CCC)		 66.87 39.48 50.25 89.10 118.18 139.84
Capital & Investment Metrics		 - - - - - -
Invested Capital		 36 53 123 271 256 61
Invested Capital Turnover		 2.63 7.19 5.01 3.17 2.34 2.12
Increase / (Decrease) in Invested Capital		 0.00 17 70 148 -15 -182
Enterprise Value (EV)		 0.00 769 577 551 368 4.13
Market Capitalization		 0.00 936 727 581 433 86
Book Value per Share		 $3.83 $2.19 $2.66 $2.90 $3.14 $1.47
Tangible Book Value per Share		 $2.62 $2.00 $2.06 $2.07 $2.43 $1.47
Total Capital		 68 229 281 330 345 129
Total Debt		 1.26 1.93 1.90 25 30 3.28
Total Long-Term Debt		 0.59 1.30 1.24 0.04 0.01 0.18
Net Debt		 -31 -174 -156 -34 -59 -64
Capital Expenditures (CapEx)		 4.09 4.73 3.20 6.84 3.56 4.34
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 3.17 23 14 134 123 37
Debt-free Net Working Capital (DFNWC)		 36 199 172 194 213 88
Net Working Capital (NWC)		 35 198 171 169 183 85
Net Nonoperating Expense (NNE)		 4.47 -4.30 -1.28 -0.76 0.45 72
Net Nonoperating Obligations (NNO)		 -31 -174 -156 -34 -59 -65
Total Depreciation and Amortization (D&A)		 5.51 7.07 11 16 16 15
Debt-free, Cash-free Net Working Capital to Revenue		 3.37% 7.29% 3.24% 21.54% 20.02% 11.48%
Debt-free Net Working Capital to Revenue		 37.83% 62.37% 38.95% 31.04% 34.50% 27.31%
Net Working Capital to Revenue		 37.12% 62.17% 38.80% 27.03% 29.63% 26.35%
Earnings Adjustments		 - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.30 $0.34 $0.07 $0.20 ($1.84)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 80.29M 101.23M 103.51M 102.40M 99.07M
Adjusted Diluted Earnings per Share		 $0.00 $0.25 $0.34 $0.06 $0.18 ($1.84)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 94.86M 102.98M 105.62M 109.42M 99.07M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 100.17M 102.51M 104.17M 101.98M 98.75M
Normalized Net Operating Profit after Tax (NOPAT)		 -7.71 19 21 17 32 -46
Normalized NOPAT Margin		 -8.19% 5.86% 4.86% 2.78% 5.20% -14.20%
Pre Tax Income Margin		 -15.55% 6.21% 5.17% 2.61% 4.50% -58.19%
Debt Service Ratios		 - - - - - -
EBIT to Interest Expense		 -70.50 33.02 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 -50.48 23.99 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 -90.47 25.39 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 -70.45 16.35 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - -
Dividend Payout Ratio		 0.00% 104.08% 0.00% 0.00% 23.52% -0.09%
Augmented Payout Ratio		 0.00% 104.08% 12.20% 0.00% 126.48% -5.60%

Quarterly Metrics And Ratios for DocGo

This table displays calculated financial ratios and metrics derived from DocGo's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 - - - - - - 101,982,549.00 99,104,331.00 97,808,137.00 97,813,372.00 98,750,251.00
DEI Adjusted Shares Outstanding		 - - - - - - 101,982,549.00 99,104,331.00 97,808,137.00 97,813,372.00 98,750,251.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - -0.09 -0.11 -0.28 -1.37 -0.15
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 78.83% 83.16% 69.98% 31.45% -25.66% -39.35% -50.01% -51.25% -48.94% -37.98% -21.33%
EBITDA Growth		 142.73% 1,835.08% 758.07% 226.93% 4.21% -115.57% -151.95% -194.78% -382.76% -3,982.63% -32.50%
EBIT Growth		 264.88% 601.01% 339.86% 1,720.52% 8.04% -148.61% -188.63% -271.85% -546.07% -1,766.48% -15.66%
NOPAT Growth		 21.94% 13,542.14% 321.58% 190.14% 15.84% -168.38% -191.52% -296.89% -676.09% -1,299.40% -33.68%
Net Income Growth		 87.73% 11.82% 370.58% 336.03% -1.83% -195.67% -204.49% -326.85% -752.45% -1,761.41% -50.73%
EPS Growth		 66.67% -45.45% 433.33% 400.00% 0.00% -150.00% -190.00% -283.33% -660.00% -4,433.33% -66.67%
Operating Cash Flow Growth		 -718.26% 32.26% 53.98% 246.54% 167.64% 317.73% 186.63% -8.90% -94.67% -182.30% -150.54%
Free Cash Flow Firm Growth		 -7,785.17% -100.64% 29.08% 39.78% 95.88% 106.96% 140.29% 199.24% 1,294.47% 375.35% 342.94%
Invested Capital Growth		 135.80% 120.48% 58.25% 44.70% 4.31% -5.54% -16.64% -32.82% -37.43% -74.96% -76.44%
Revenue Q/Q Growth		 48.66% 6.80% -3.59% -14.13% -15.92% -12.87% -20.52% -16.26% -11.95% 5.83% 0.82%
EBITDA Q/Q Growth		 201.76% 27.22% 20.83% -29.52% -3.81% -119.01% -302.88% -28.60% -186.94% -174.62% 86.92%
EBIT Q/Q Growth		 1,498.18% 37.34% 32.22% -37.27% -5.15% -161.79% -141.04% -21.61% -146.19% -158.64% 85.06%
NOPAT Q/Q Growth		 105.57% 73.75% 39.94% -41.95% -17.93% -202.56% -87.30% -24.88% -140.14% -149.14% 82.11%
Net Income Q/Q Growth		 244.61% 72.63% 32.65% -44.75% -22.41% -268.23% -44.89% -19.95% -123.16% -379.95% 88.27%
EPS Q/Q Growth		 350.00% 20.00% 66.67% -40.00% -16.67% -160.00% -200.00% -22.22% -154.55% -385.71% 88.97%
Operating Cash Flow Q/Q Growth		 -529.04% 87.10% -79.76% 448.28% -16.25% -58.47% -27.53% 248.04% -95.06% -731.04% 55.50%
Free Cash Flow Firm Q/Q Growth		 -5.80% 1.00% 27.79% 20.06% 92.77% 267.29% 77.76% 96.89% -12.94% 56.01% 65.64%
Invested Capital Q/Q Growth		 30.56% 6.71% 12.21% -7.25% -5.89% -3.36% 4.16% -25.25% -12.35% -63.30% -2.01%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 29.51% -49.26% 35.03% 100.00% 100.00% -130.21% 100.00% 100.00% 100.00% -198.17% 100.00%
EBITDA Margin		 7.10% 8.46% 10.60% 8.70% 9.95% -2.17% -11.01% -16.91% -55.11% -143.00% -18.55%
Operating Margin		 4.67% 5.86% 8.26% 6.15% 7.31% -6.18% -14.58% -21.74% -59.28% -139.56% -24.77%
EBIT Margin		 4.77% 6.14% 8.42% 6.15% 6.94% -4.92% -14.93% -21.68% -60.62% -148.14% -21.95%
Profit (Net Income) Margin		 2.48% 4.01% 5.52% 3.55% 3.28% -6.33% -11.54% -16.53% -41.88% -189.95% -22.10%
Tax Burden Percent		 50.57% 65.54% 67.44% 61.23% 50.31% 116.30% 74.85% 74.18% 68.70% 127.53% 100.12%
Interest Burden Percent		 102.82% 99.71% 97.21% 94.31% 93.89% 110.58% 103.26% 102.77% 100.58% 100.54% 100.60%
Effective Tax Rate		 49.44% 34.46% 32.56% 38.77% 49.69% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 6.97% 12.17% 15.84% 11.76% 9.85% -10.13% -19.09% -28.20% -70.95% -207.32% -33.47%
ROIC Less NNEP Spread (ROIC-NNEP)		 6.74% 11.81% 16.03% 12.33% 10.99% -4.96% -14.87% -26.64% -70.59% -106.68% -26.31%
Return on Net Nonoperating Assets (RNNOA)		 -2.41% -3.85% -2.78% -2.58% -1.74% 0.75% 1.46% 5.95% 18.68% 33.24% 6.41%
Return on Equity (ROE)		 4.56% 8.33% 13.06% 9.18% 8.11% -9.38% -17.63% -22.25% -52.26% -174.08% -27.07%
Cash Return on Invested Capital (CROIC)		 -72.57% -70.47% -35.25% -24.38% 7.28% 10.94% 17.85% 30.68% 19.73% 37.80% 41.86%
Operating Return on Assets (OROA)		 6.57% 8.67% 13.19% 10.40% 10.55% -6.41% -16.86% -21.09% -52.64% -141.90% -20.69%
Return on Assets (ROA)		 3.42% 5.67% 8.65% 6.01% 4.99% -8.25% -13.03% -16.07% -36.38% -181.95% -20.84%
Return on Common Equity (ROCE)		 4.48% 8.18% 12.86% 9.08% 8.06% -9.41% -17.73% -22.50% -53.17% -183.51% -28.93%
Return on Equity Simple (ROE_SIMPLE)		 3.20% 0.00% 7.89% 9.23% 8.92% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 4.40 7.65 11 6.21 5.10 -5.23 -9.80 -12 -29 -73 -13
NOPAT Margin		 2.36% 3.84% 5.57% 3.77% 3.68% -4.33% -10.20% -15.22% -41.50% -97.69% -17.34%
Net Nonoperating Expense Percent (NNEP)		 0.23% 0.36% -0.20% -0.57% -1.14% -5.17% -4.22% -1.56% -0.35% -100.63% -7.16%
Return On Investment Capital (ROIC_SIMPLE)		 - 2.32% - - - -1.52% -2.95% -3.85% -11.26% -56.68% -10.96%
Cost of Revenue to Revenue		 70.49% 149.26% 64.98% 0.00% 0.00% 230.21% 0.00% 0.00% 0.00% 298.17% 0.00%
SG&A Expenses to Revenue		 18.02% 21.84% 20.92% 21.07% 20.76% 29.00% 34.26% 38.85% 42.50% 52.33% 40.81%
R&D to Revenue		 1.73% 1.60% 1.24% 1.44% 2.27% 3.05% 3.79% 3.68% 4.51% 5.03% 4.90%
Operating Expenses to Revenue		 24.84% -55.12% 26.84% 93.85% 92.69% -124.15% 114.58% 121.74% 159.28% -58.61% 124.77%
Earnings before Interest and Taxes (EBIT)		 8.91 12 16 10 9.62 -5.95 -14 -17 -43 -111 -17
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 13 17 20 14 14 -2.62 -11 -14 -39 -107 -14
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.92 1.93 1.35 1.00 1.04 1.35 0.87 0.52 0.49 0.60 0.47
Price to Tangible Book Value (P/TBV)		 2.75 2.69 1.85 1.35 1.40 1.75 1.16 0.71 0.63 0.60 0.47
Price to Revenue (P/Rev)		 1.04 0.93 0.60 0.42 0.49 0.70 0.52 0.36 0.36 0.27 0.21
Price to Earnings (P/E)		 75.23 84.68 19.48 10.43 11.02 21.64 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 1.33% 1.18% 5.13% 9.59% 9.07% 4.62% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 2.05 2.03 1.36 1.00 1.05 1.44 0.84 0.27 0.20 0.07 0.01
Enterprise Value to Revenue (EV/Rev)		 0.97 0.88 0.59 0.38 0.40 0.60 0.41 0.12 0.09 0.01 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 28.34 17.55 7.51 4.32 4.27 8.02 14.24 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 162.27 36.85 10.88 5.90 5.80 12.26 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 34.58 59.34 16.86 9.68 9.37 26.62 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 5.42 5.23 2.37 0.59 0.56 0.12 0.03
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 14.79 12.76 4.29 0.72 0.76 0.07 0.01
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.05 0.08 0.10 0.09 0.09 0.10 0.10 0.10 0.00 0.03 0.07
Long-Term Debt to Equity		 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.36 -0.33 -0.17 -0.21 -0.16 -0.15 -0.10 -0.22 -0.26 -0.31 -0.24
Leverage Ratio		 1.38 1.51 1.50 1.46 1.48 1.53 1.49 1.48 1.45 1.53 1.55
Compound Leverage Factor		 1.42 1.51 1.46 1.38 1.39 1.69 1.54 1.52 1.46 1.53 1.56
Debt to Total Capital		 5.12% 7.59% 8.71% 8.63% 8.47% 8.70% 9.04% 9.45% 0.10% 2.54% 6.96%
Short-Term Debt to Total Capital		 4.46% 7.58% 8.70% 8.63% 8.46% 8.69% 9.04% 9.45% 0.02% 2.39% 6.82%
Long-Term Debt to Total Capital		 0.67% 0.01% 0.01% 0.01% 0.01% 0.00% 0.00% 0.00% 0.08% 0.14% 0.14%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 1.29% 1.33% 1.09% 0.81% -0.09% -1.66% -2.23% -3.00% -3.78% -14.05% -17.65%
Common Equity to Total Capital		 93.59% 91.08% 90.20% 90.55% 91.62% 92.97% 93.19% 93.56% 103.69% 111.51% 110.69%
Debt to EBITDA		 0.86 0.80 0.55 0.46 0.46 0.65 2.01 -2.31 0.00 -0.02 -0.05
Net Debt to EBITDA		 -2.05 -1.09 -0.21 -0.56 -0.92 -1.29 -3.28 7.25 1.38 0.37 0.23
Long-Term Debt to EBITDA		 0.11 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 1.05 2.70 1.23 1.04 1.01 2.17 -36.21 -1.49 0.00 -0.03 -0.07
Net Debt to NOPAT		 -2.50 -3.69 -0.48 -1.26 -2.01 -4.29 59.11 4.67 1.60 0.51 0.32
Long-Term Debt to NOPAT		 0.14 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 4.27 3.59 3.38 3.12 3.12 3.64 2.75 2.03 1.70 -0.35 0.58
Noncontrolling Interest Sharing Ratio		 1.88% 1.72% 1.50% 1.15% 0.59% -0.22% -0.59% -1.11% -1.74% -5.41% -6.90%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.36 1.99 2.09 2.13 2.19 2.50 2.44 2.36 2.59 2.26 1.79
Quick Ratio		 2.30 1.89 2.03 2.10 2.15 2.46 2.40 2.27 2.45 2.13 1.68
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -142 -140 -101 -81 -5.84 9.77 41 80 70 109 180
Operating Cash Flow to CapEx		 -5,704.99% -215.16% -1,148.13% 3,235.64% 4,495.30% 1,616.12% 985.45% 5,424.22% 193.93% -701.06% -1,140.48%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 -273.66 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 -28.83 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 -31.34 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.38 1.41 1.57 1.69 1.52 1.30 1.13 0.97 0.87 0.96 0.94
Accounts Receivable Turnover		 3.72 3.42 3.39 3.95 3.15 2.61 2.25 2.29 2.16 2.12 2.21
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 27.08 32.78 36.98 39.16 37.43 38.88 33.19 28.66 24.88 21.89 21.03
Accounts Payable Turnover		 12.80 20.72 24.80 29.54 19.15 16.73 17.47 19.69 18.66 11.32 13.00
Days Sales Outstanding (DSO)		 98.23 106.72 107.61 92.38 115.82 140.00 161.95 159.18 168.93 172.08 164.96
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 28.51 17.62 14.72 12.36 19.06 21.82 20.90 18.53 19.56 32.24 28.09
Cash Conversion Cycle (CCC)		 69.72 89.10 92.89 80.02 96.76 118.18 141.05 140.64 149.37 139.84 136.88
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 254 271 303 281 265 256 253 189 166 61 60
Invested Capital Turnover		 2.95 3.17 2.84 3.12 2.68 2.34 1.87 1.85 1.71 2.12 1.93
Increase / (Decrease) in Invested Capital		 146 148 112 87 11 -15 -50 -92 -99 -182 -193
Enterprise Value (EV)		 519 551 412 280 279 368 213 52 32 4.13 0.55
Market Capitalization		 553 581 420 314 340 433 269 156 133 86 62
Book Value per Share		 $2.77 $2.90 $3.00 $3.10 $3.18 $3.14 $3.03 $3.00 $2.77 $1.47 $1.34
Tangible Book Value per Share		 $1.94 $2.07 $2.19 $2.28 $2.37 $2.43 $2.28 $2.23 $2.16 $1.47 $1.33
Total Capital		 307 330 345 348 355 345 332 318 261 129 120
Total Debt		 16 25 30 30 30 30 30 30 0.25 3.28 8.32
Total Long-Term Debt		 2.04 0.04 0.03 0.03 0.02 0.01 0.00 0.00 0.20 0.18 0.17
Net Debt		 -38 -34 -12 -37 -60 -59 -49 -94 -91 -64 -40
Capital Expenditures (CapEx)		 0.80 2.75 0.93 1.15 0.69 0.80 0.94 0.62 0.86 1.49 0.41
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 115 134 164 139 119 123 106 62 43 37 33
Debt-free Net Working Capital (DFNWC)		 168 194 205 205 208 213 185 166 117 88 69
Net Working Capital (NWC)		 154 169 175 175 178 183 155 136 117 85 61
Net Nonoperating Expense (NNE)		 -0.23 -0.34 0.10 0.36 0.55 2.42 1.28 1.05 0.27 69 3.60
Net Nonoperating Obligations (NNO)		 -38 -34 -12 -37 -60 -59 -49 -99 -95 -65 -52
Total Depreciation and Amortization (D&A)		 4.34 4.62 4.18 4.20 4.18 3.32 3.76 3.84 3.90 3.85 2.57
Debt-free, Cash-free Net Working Capital to Revenue		 21.52% 21.54% 23.28% 18.65% 17.07% 20.02% 20.36% 14.28% 11.77% 11.48% 11.08%
Debt-free Net Working Capital to Revenue		 31.43% 31.04% 29.15% 27.55% 29.95% 34.50% 35.54% 38.18% 31.70% 27.31% 22.90%
Net Working Capital to Revenue		 28.86% 27.03% 24.88% 23.50% 25.63% 29.63% 29.77% 31.29% 31.69% 26.35% 20.20%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.05 $0.07 $0.11 $0.06 $0.05 ($0.02) ($0.09) ($0.11) ($0.28) ($1.36) ($0.15)
Adjusted Weighted Average Basic Shares Outstanding		 103.87M 103.51M 103.82M 101.84M 102.07M 102.40M 101.59M 98.93M 97.81M 99.07M 98.75M
Adjusted Diluted Earnings per Share		 $0.05 $0.06 $0.10 $0.06 $0.05 ($0.03) ($0.09) ($0.11) ($0.28) ($1.36) ($0.15)
Adjusted Weighted Average Diluted Shares Outstanding		 104.99M 105.62M 108.51M 106.32M 106.29M 109.42M 101.59M 98.93M 97.81M 99.07M 98.75M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 103.90M 104.17M 101.57M 102.32M 102.05M 101.98M 99.10M 97.81M 97.81M 98.75M 98.78M
Normalized Net Operating Profit after Tax (NOPAT)		 6.20 9.94 14 8.67 6.76 -1.36 -6.85 -9.19 -14 -67 -9.57
Normalized NOPAT Margin		 3.32% 4.99% 7.09% 5.26% 4.87% -1.13% -7.13% -11.43% -19.29% -88.79% -12.67%
Pre Tax Income Margin		 4.91% 6.12% 8.19% 5.80% 6.51% -5.44% -15.41% -22.28% -60.96% -148.94% -22.08%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 43.83 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 29.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 41.32 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 26.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 23.52% 0.00% -10.53% -1.98% -0.09% -0.59%
Augmented Payout Ratio		 35.14% 0.00% 19.85% 33.63% 38.20% 126.48% -175.81% -64.42% -23.88% -5.60% -3.11%

Financials Breakdown Chart

Key Financial Trends

DocGo’s latest quarter shows a mixed but improving operating picture, with revenue holding steady year over year while losses remain significant. In Q1 2026, revenue rose modestly to $75.6 million from $74.9 million in Q4 2025, but the company still posted a net loss of $16.7 million. The more encouraging takeaway is that operating cash flow was less negative than the prior quarter, and DocGo continued to maintain a sizable cash and investment base.

  • Revenue was stable year over year in Q1 2026. Sales of $75.6 million were slightly above Q4 2025’s $74.9 million, suggesting the top line has at least stabilized after a weaker stretch.
  • Operating cash flow improved versus the prior quarter. Q1 2026 operating cash outflow was $4.7 million, better than the $10.5 million outflow in Q4 2025.
  • Investing cash flow turned positive in Q1 2026. DocGo generated $1.7 million of net cash from investing activities, helped by sales and maturities of investments.
  • The balance sheet still shows meaningful liquidity. DocGo ended Q1 2026 with $35.7 million in cash and equivalents, plus $13.1 million in long-term investments.
  • Debt remains low relative to the balance sheet. Long-term debt was just $171,714 at quarter-end, with short-term debt of $8.1 million.
  • Gross profit is not being presented in a typical way in the reported statements. The income statement shows no cost of revenue in Q1 2026, so investors should focus more on operating income and cash generation than headline gross margin figures.
  • Working capital remains a major balance sheet item. Accounts receivable were $94.0 million, and accrued expenses were $44.7 million, so collections and payables management will remain important.
  • Share count remains high. Weighted average diluted shares outstanding were about 98.7 million in Q1 2026, which can limit per-share earnings recovery.
  • The company continued paying dividends and other financing costs. Dividend payments and other financing activities still consumed cash in the quarter, which may be notable given ongoing losses.
  • DocGo remains unprofitable. Q1 2026 net loss was $16.7 million, or $0.15 per share.
  • Operating income was still negative. Q1 2026 operating loss came in at $18.7 million, showing core operations are not yet consistently profitable.
  • Operating cash flow turned negative again. Despite some improvement quarter over quarter, the business still burned cash from operations.
  • Losses were much worse in late 2025. Q4 2025 saw a net loss of $142.3 million and a steep operating loss, underscoring that profitability has been volatile.
  • Revenue is well below 2024 levels. Compared with Q1 2024 revenue of $192.1 million, Q1 2026 revenue is materially lower, indicating the business has not returned to prior peak levels.
  • The company’s historical cash trend has weakened. Cash and equivalents fell from $79.0 million in Q1 2025 to $35.7 million in Q1 2026, reflecting ongoing cash usage and financing needs over time.

Bottom line: DocGo’s Q1 2026 results suggest a company that is still under pressure but showing some stability in revenue and a better operating-cash trend than the immediately preceding quarter. The main investor question remains whether management can translate that stabilization into sustained profitability and positive cash flow.

07/14/26 11:21 PM ETAI Generated. May Contain Errors.

DocGo Financials - Frequently Asked Questions

According to the most recent income statement we have on file, DocGo's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

DocGo's net income appears to be on an upward trend, with a most recent value of -$196.37 million in 2025, rising from -$14.80 million in 2020. The previous period was $13.36 million in 2024. Find out what analysts predict for DocGo in the coming months.

DocGo's total operating income in 2025 was -$178.03 million, based on the following breakdown:
  • Total Gross Profit: $98.76 million
  • Total Operating Expenses: $276.79 million

Over the last 5 years, DocGo's total revenue changed from $94.09 million in 2020 to $322.20 million in 2025, a change of 242.4%.

DocGo's total liabilities were at $91.23 million at the end of 2025, a 35.0% decrease from 2024, and a 174.6% increase since 2020.

In the past 5 years, DocGo's cash and equivalents has ranged from $32.42 million in 2020 to $175.54 million in 2021, and is currently $51.02 million as of their latest financial filing in 2025.

Over the last 5 years, DocGo's book value per share changed from 3.83 in 2020 to 1.47 in 2025, a change of -61.5%.


Related Companies

Financial statements for NASDAQ:DCGO last updated on 7/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Trump’s $250 Bill – See Immediately
Former Goldman Sachs VP Dr. David Eifrig is warning that July 28 could trigger the biggest wealth reset in mod...
Stansberry Research | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Trump Admin to Pump $1 Billion into this “Off-the-Radar” AI Stock
The U.S. government pumped more than $1 billion into Intel. The stock popped 128%. It pumped $400 million into...
InvestorPlace | Sponsoredtc pixel
Trump's Next Move Could Shrink Your Dollar
There's a plan in Washington being called the 'Mar-a-Lago Accord' - a deliberate strategy to weaken the U.S. d...
Priority Gold | Sponsoredtc pixel
PH: Do THESE 4 things to your bank account now …
In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...
Weiss Ratings | Sponsoredtc pixel
60 years. Zero competitors.
One company has spent 60 years developing an energy source the International Energy Agency estimates at 140 ti...
Behind the Markets | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
SpaceX Opens Up 11% — Here’s What You Need to Know
SpaceX - ticker SPCX - just completed the biggest IPO in American history, raising $75 billion at a $1.8 trill...
Porter & Company | Sponsoredtc pixel